Project is the latest in the quest to protect health quickly in a bioterrorism attack
Washington, DC–(ENEWSPF)–August 17, 2015. A new anthrax vaccine that could be easier and faster to produce than the existing licensed product will undergo initial clinical studies through an agreement between the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) and Pfenex, Inc. of San Diego.
The anthraxvaccine currently…
